Publication Archive
Min T, Barry JD and Stephens JW. Predicting the Resolution of Type 2 Diabetes after Bariatric Surgical Procedures: A Concise Review. J Diabetes Metab. 2015 October 19; 6:617. doi:10.4172/2155-6156.1000617
Monnier L, Colette C, Dejager S, Owens D. The dawn phenomenon in type 2 diabetes: how to assess it in clinical practice? Diabetes Metab. 2015 Apr;41(2):132-7. doi: 10.1016/j.diabet.2014.10.002. Epub 2014 Nov 6. PMID: 25457475
Alhadj Ali M, Thrower SL, Hanna SJ, Coulman SA, Birchall JC, Wong FS, Dayan CM, Tatovic D. Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin. Immunology. 2015 Nov;146(3):411-22. doi: 10.1111/imm.12518. Epub 2015 Sep 13. PMID: 26293297
Thabit H, et al; AP@home Consortium. Home Use of an Artificial Beta Cell in Type 1 Diabetes. 2015
Elleri D, et al. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial. 2015
Kropff J, et al. AP@home consortium. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. 2015
Mallipedhi A, et al. Association between the preoperative fasting and postprandial C-peptide AUC with resolution of type 2 diabetes 6 months following bariatric surgery. 2015
Dunseath G, et al. Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus. 2015
Mallipedhi A, et al. Changes in plasma levels of N-arachidonoyl ethanolamine and N-palmitoylethanolamine following bariatric surgery in morbidly obese females with impaired glucose homeostasis. 2015